NABL Certified Labs

Book CA-125 Test in Muzaffarpur

35+ Regional Processing Labs
4500+ Serviceable Pincodes across India
75000+ Samples Processed Daily

Test Price

₹1,399

Book Now
Free Home Collection Reports in 24 Hrs

Quick Ca 125 Test Overview in Muzaffarpur

Also Known As Cancer Antigen 125 Test, Ovarian Cancer Marker Test
Sample Type Blood (Venous)
Fasting Required No
Report Delivery Within 24 hours
Age Group Adult women
Gender Female
Test Type Immunoassay
Units U/mL (Units per millilitre)
1

The CA-125 test is a blood test that measures the level of Cancer Antigen 125, a protein found on the surface of many ovarian cancer cells and released into the bloodstream. CA-125 is the most widely used tumour marker for ovarian cancer and is an essential component of ovarian cancer diagnosis, monitoring, and follow-up in women across India and globally. While CA-125 is most strongly associated with ovarian cancer, it is important to understand that elevated levels can also be seen in several non-cancerous conditions, which is why the test is always interpreted alongside clinical examination, imaging, and other investigations rather than in isolation. Ovarian cancer is one of the most serious gynaecological cancers affecting Indian women and is often referred to as the silent cancer because it frequently produces no significant symptoms in its early stages. By the time symptoms such as abdominal bloating, pelvic pain, and changes in bowel or bladder habits become noticeable, the disease has often already advanced to a later stage. This makes early detection through CA-125 testing alongside transvaginal ultrasound a critically important strategy for women at high risk of ovarian cancer, including those with a family history of ovarian or breast cancer and those carrying BRCA gene mutations. The test involves a simple blood draw of approximately 2 ml from a vein in the arm and is completed in under five minutes.
2

Doctors prescribe a CA-125 test in the following situations: Investigating a pelvic mass or ovarian cyst detected on ultrasound to determine whether the mass has features that suggest malignancy. An elevated CA-125 alongside a suspicious pelvic mass significantly increases the likelihood of ovarian cancer and guides the decision for surgical intervention. Monitoring the response to chemotherapy in women diagnosed with ovarian cancer. A falling CA-125 during treatment confirms that the cancer is responding. A rising CA-125 during or after treatment may indicate disease progression or recurrence. Detecting ovarian cancer recurrence after initial treatment. CA-125 is the most sensitive early marker of recurrence and often rises months before recurrence becomes visible on imaging. Screening high-risk women including those with a family history of ovarian or breast cancer, BRCA1 or BRCA2 gene mutation carriers, and women with Lynch syndrome, where regular CA-125 monitoring alongside ultrasound is recommended. Investigating endometriosis in women with chronic pelvic pain, painful periods, or infertility, as CA-125 is frequently elevated in moderate to severe endometriosis and can help assess disease severity. Evaluating other gynaecological conditions including uterine fibroids, pelvic inflammatory disease, and adenomyosis where CA-125 can be mildly elevated. Assessing non-gynaecological cancers including pancreatic, lung, liver, and colorectal cancers where CA-125 can occasionally be elevated as a secondary marker.
3

The CA-125 test measures the concentration of Cancer Antigen 125 protein in the blood, reported in units per millilitre (U/mL). Normal CA-125 Range The standard reference range used across most Indian diagnostic laboratories and oncology centres is as follows. A CA-125 level below 35 U/mL is considered within the normal range in adult women who are not pregnant and not menstruating at the time of testing. Interpreting CA-125 Results A CA-125 level between 35 and 200 U/mL is considered mildly to moderately elevated. At this level, non-cancerous causes such as endometriosis, uterine fibroids, pelvic inflammatory disease, liver cirrhosis, and even normal menstruation must be considered before drawing any conclusion about malignancy. A CA-125 level above 200 U/mL is considered significantly elevated and raises a stronger concern for ovarian or other malignancy, particularly when accompanied by a suspicious pelvic mass on ultrasound. This level warrants urgent gynaecological or oncological evaluation. A CA-125 level above 500 U/mL in a postmenopausal woman with a pelvic mass is highly suggestive of advanced ovarian cancer and requires immediate specialist management. It is important to note that CA-125 can be elevated in a variety of benign conditions and a single elevated reading does not confirm cancer. Equally, a normal CA-125 does not completely rule out ovarian cancer as approximately 20% of ovarian cancers, particularly early-stage and mucinous cancers, do not produce elevated CA-125.
4

Preparation for a CA-125 test is minimal. Fasting is not required. You can eat and drink normally before sample collection. If CA-125 is part of a larger panel that includes fasting tests, fast as advised by your doctor. Our team confirms preparation requirements at the time of booking. Inform your doctor and the phlebotomist if you are currently menstruating. CA-125 levels are naturally higher during menstruation and can produce a mildly elevated result that is not clinically significant. Ideally the test should be done after the menstrual period has ended for the most accurate interpretation. Inform the phlebotomist about all medications, hormonal therapies, and supplements you are currently taking as these can influence CA-125 levels. Stay normally hydrated before sample collection. Drinking water normally before the test is recommended. There are no dietary or lifestyle restrictions specific to the CA-125 test beyond the guidance above.
5

If you are booking through SecondMedic platform the CA-125 test price in Muzaffarpur can cost you around Rs. 1,399. The exact price for your CA-125 test in Muzaffarpur will be confirmed at the time of booking through SecondMedic. If your doctor has prescribed multiple tests alongside CA-125, SecondMedic health packages available in Muzaffarpur include CA-125 as part of a broader gynaecological or oncology panel at a significantly lower combined price.
6

SecondMedic provides home sample collection for CA-125 test across all major areas of Muzaffarpur. You do not need to visit a lab or collection centre. A certified and trained phlebotomist comes to your home or workplace at your chosen time, collects the sample using sterile single-use equipment, and ensures it is transported to the NABL-accredited lab within the required time window for accurate processing. Please note that SecondMedic provides free home sample collection on all tests priced above Rs. 300. Our team will check your pincode and confirm if your address in Muzaffarpur falls under our free sample collection eligibility criteria, which depends upon the lab location and phlebotomist availability. Home collection in Muzaffarpur is available between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Enter your pincode on the booking page or call our helpline to confirm availability at your address in Muzaffarpur.

Our Presence In India

People Also Ask

Yes, CA-125 test is available in Muzaffarpur through SecondMedic with home collection and walk-in options. As a critical oncology marker, SecondMedic ensures CA-125 testing is accessible across all major serviceable areas in Muzaffarpur with NABL-accredited processing.

If you are booking through SecondMedic platform the CA-125 test price in Muzaffarpur can cost you around Rs. 1,399. The exact price will be confirmed at the time of booking and may vary if booked as part of a broader gynaecological or oncology panel.

Your CA-125 report will be delivered within 24 hours of sample collection in Muzaffarpur directly on WhatsApp and email. No physical visit to any centre in Muzaffarpur is required to collect the report.

All CA-125 samples collected in Muzaffarpur are processed at NABL-accredited partner laboratories using validated immunoassay technology. Accurate CA-125 measurement is critical as chemotherapy monitoring and cancer recurrence decisions are directly based on serial CA-125 values.

Yes, SecondMedic provides home sample collection for CA-125 test across all major areas of Muzaffarpur. This is particularly valuable for women undergoing cancer treatment or post-surgical monitoring who are advised to minimise unnecessary travel and exposure.

Yes, home collection for CA-125 test in Muzaffarpur is available on Sundays and all public holidays between 7 AM and 10 PM. Women on regular oncology monitoring schedules can book any day without any scheduling constraints.

CA-125 is prescribed as the primary tumour marker for ovarian cancer to investigate suspicious pelvic masses, monitor chemotherapy response, and detect cancer recurrence after treatment. It is also ordered in women with suspected endometriosis where elevated CA-125 correlates with disease severity.

A CA-125 level below 35 U/mL is considered normal in adult women. Levels during menstruation can be naturally higher and are not always clinically significant, which is why the test is ideally performed after the menstrual period has ended.

A CA-125 above 35 U/mL may indicate ovarian cancer, endometriosis, uterine fibroids, or other benign gynaecological conditions and must always be interpreted alongside ultrasound findings and clinical symptoms. A level above 200 U/mL with a suspicious pelvic mass warrants urgent gynaecological evaluation.

Content Reviewed By

Reviewer
Reviewed by:

Dr. Kovid Pandey

MBBS, General Physician

Last Reviewed: 10th Mar 2026

References

1
American Cancer Society: Ovarian Cancer Early Detection, Diagnosis, and Staging, ACS, 2023 — www.cancer.org
2
National Cancer Institute: Tumor Markers in Common Use, NCI, 2023 — www.cancer.gov
3
Jacobs IJ, Menon U: Progress and Challenges in Screening for Early Detection of Ovarian Cancer, Molecular and Cellular Proteomics, 2004 — pubmed.ncbi.nlm.nih.gov
4
Indian Council of Medical Research: Consensus Document for Management of Ovarian Cancer, ICMR, 2016 — www.icmr.gov.in
5
Bast RC et al.: A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer, New England Journal of Medicine, 1983 — pubmed.ncbi.nlm.nih.gov

Download Our App & Get Consultation from anywhere.

App Download